Thrivent Financial for Lutherans’s Axon Enterprise AXON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Sell
23,751
-129
-0.5% -$67K 0.02% 630
2025
Q4
$13.6M Sell
23,880
-88,964
-79% -$55.2M 0.02% 562
2025
Q3
$81M Sell
112,844
-4,675
-4% -$3.55M 0.16% 150
2025
Q2
$97.3M Sell
117,519
-31,848
-21% -$21.7M 0.21% 111
2025
Q1
$78.7M Sell
149,367
-76,962
-34% -$45M 0.17% 150
2024
Q4
$135M Sell
226,329
-27,754
-11% -$15.1M 0.26% 72
2024
Q3
$102M Sell
254,083
-16,347
-6% -$5.64M 0.19% 130
2024
Q2
$79.6M Buy
270,430
+4,365
+2% +$1.3M 0.16% 164
2024
Q1
$83.2M Buy
266,065
+1,910
+0.7% +$531K 0.17% 166
2023
Q4
$68.2M Sell
264,155
-120,292
-31% -$27.1M 0.15% 198
2023
Q3
$76.5M Buy
384,447
+381,459
+12,766% +$75M 0.18% 150
2023
Q2
$583K Sell
2,988
-14,854
-83% -$3.08M ﹤0.01% 2115
2023
Q1
$4.01M Sell
17,842
-166
-0.9% -$33K 0.01% 901
2022
Q4
$2.99M Buy
18,008
+137
+0.8% +$21.7K 0.01% 1007
2022
Q3
$2.07M Sell
17,871
-759
-4% -$86K 0.01% 1195
2022
Q2
$1.74M Buy
18,630
+739
+4% +$78.1K ﹤0.01% 1320
2022
Q1
$2.46M Buy
17,891
+574
+3% +$78.7K ﹤0.01% 1200
2021
Q4
$2.72M Buy
17,317
+150
+0.9% +$25.2K 0.01% 1194
2021
Q3
$3M Sell
17,167
-4
-0% -$727 0.01% 1113
2021
Q2
$3.04M Sell
17,171
-40,986
-70% -$6.03M 0.01% 1166
2021
Q1
$8.28M Buy
58,157
+41,519
+250% +$6.47M 0.02% 729
2020
Q4
$2.04M Sell
16,638
-458
-3% -$52.5K ﹤0.01% 1304
2020
Q3
$1.55M Sell
17,096
-259
-1% -$22.5K ﹤0.01% 1306
2020
Q2
$1.7M Buy
17,355
+1,850
+12% +$150K 0.01% 1156
2020
Q1
$1.1M Hold
15,505
﹤0.01% 1253
2019
Q4
$1.14M Buy
15,505
+120
+0.8% +$7.59K ﹤0.01% 1376
2019
Q3
$874K Sell
15,385
-254
-2% -$16K ﹤0.01% 1501
2019
Q2
$1M Sell
15,639
-29,017
-65% -$1.89M ﹤0.01% 1397
2019
Q1
$2.43M Buy
44,656
+3,468
+8% +$178K 0.01% 872
2018
Q4
$1.8M Buy
41,188
+1,064
+3% +$55.2K 0.01% 874
2018
Q3
$2.75M Buy
40,124
+687
+2% +$46.3K 0.01% 785
2018
Q2
$2.49M Buy
39,437
+3,736
+10% +$202K 0.01% 822
2018
Q1
$1.4M Buy
35,701
+2,782
+8% +$86.8K ﹤0.01% 1053
2017
Q4
$872K Buy
32,919
+30,919
+1,546% +$743K ﹤0.01% 1336
2017
Q3
$45K Buy
+2,000
New +$46.8K ﹤0.01% 1990
2017
Q2
Sell
-29,420
Closed -$670K 2026
2017
Q1
$670K Buy
29,420
+1,670
+6% +$41K ﹤0.01% 1382
2016
Q4
$673K Sell
27,750
-22,010
-44% -$543K ﹤0.01% 1360
2016
Q3
$1.42M Buy
49,760
+24,180
+95% +$671K 0.01% 988
2016
Q2
$636K Buy
25,580
+1,330
+5% +$27.5K ﹤0.01% 1303
2016
Q1
$476K Buy
24,250
+1,210
+5% +$20.8K ﹤0.01% 1385
2015
Q4
$398K Buy
23,040
+690
+3% +$13.8K ﹤0.01% 1453
2015
Q3
$492K Buy
22,350
+1,550
+7% +$40.9K ﹤0.01% 1216
2015
Q2
$693K Buy
20,800
+1,500
+8% +$46.9K ﹤0.01% 956
2015
Q1
$465K Buy
19,300
+200
+1% +$5.09K ﹤0.01% 1147
2014
Q4
$506K Buy
19,100
+100
+0.5% +$1.97K ﹤0.01% 1109
2014
Q3
$293K Sell
19,000
-900
-5% -$12.7K ﹤0.01% 1382
2014
Q2
$265K Buy
19,900
+950
+5% +$14.1K ﹤0.01% 1466
2014
Q1
$347K Buy
+18,950
New +$339K ﹤0.01% 1153

Other funds holding AXON

Thrivent Financial for Lutherans's AXON Position: Q1 2026 in Review

Thrivent Financial for Lutherans reduced its Axon Enterprise (AXON) stake by 0.54% in Q1 2026, selling an estimated $67K and leaving 23,751 shares worth $10.1M. The position accounts for 0.02% of the portfolio, ranked #630.

Thrivent Financial for Lutherans first reported a position in AXON in Q1 2014 and has held it in 48 quarters since. The position peaked at $135M in Q4 2024. 1,048 funds tracked by Wall St. Rank hold AXON as of Q1 2026.

  • Thrivent Financial for Lutherans held 23,751 shares of Axon Enterprise worth $10.1M as of Q1 2026.
  • Thrivent Financial for Lutherans sold 129 Axon Enterprise shares in Q1 2026, an estimated $67K.
  • Axon Enterprise made up 0.02% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #630 holding.
  • Thrivent Financial for Lutherans first reported a position in Axon Enterprise in Q1 2014 and has held it in 48 quarters since.
  • Thrivent Financial for Lutherans's Axon Enterprise position peaked at $135M in Q4 2024.
  • 1,048 funds tracked by Wall St. Rank held Axon Enterprise as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.